Scientific Expertise

Dec 1-3

RT-qPCR and Sequencing Testing Supporting SARS-CoV-2 Vaccine Clinical Trials

Presented By Mark Wissel

Nov 19

This informative webinar; featuring Karina Eterovic, PhD, R&D Director of Oncology Diagnostics at Eurofins Viracor, entitled: Exploring the application of comprehensive genomic profiling in oncology therapy development.

Sept 28 - Oct 1

qPCR/sequencing assay development to support vaccine clinical studies and trials

Presented by Mark Wissel

Jul 29

Eurofins Viracor invites you to add the upcoming event to your calendar. This informative webinar, featuring our flow cytometry expert, Dr. Brian Maybruck, will focus on the use of Flow Cytometry for rare cell quantitation, and its application in drug development.

Flow cytometry is a very powerful and reliable alternative to many other methods used for clinical drug development. Consider that it can simultaneously measure multiple parameters on tens of thousands of cells, with a resolution down to a single cell level, robustly and rapidly (greater than 1000 samples per day).

Check out the latest BioPharma Services newsletter from the Eurofins Group to learn about new services and analytical techniques, research projects, major events and other related topics.

Check out the latest BioPharma Services newsletter from the Eurofins Group to learn about new services and analytical techniques, research projects, major events and other related topics.

Click here to check out the Bioanalysis ZONE podcast on T-cell immunity monitoring and assay development, featuring Steven Kleiboeker, PhD, our VP of Research & Development at Eurofins Viracor BioPharma.

A large global pharmaceutical company, with a promising new vaccine candidate, partnered with Eurofins Viracor BioPharma to perform immunogenicity testing as part of their clinical trial development. Several specific areas of expertise were called upon to enable the Eurofins Viracor BioPharma team to deliver multiple precise, robust and sensitive assays to meet the sponsor's needs.

Immunotherapies have emerged as some of the most promising approaches to treating cancer patients. Download the Info Sheet to see what assay development and testing services Eurofins Viracor BioPharma offers for supporting clinical development of Cell & Gene therapy candidates.